Vident Advisory’s Novartis NVS Stock Holding History

Vident Advisory's NVS Position: Q2 2026 in Review

Vident Advisory increased its Novartis (NVS) stake by 2% in Q2 2026, buying an estimated $128K and bringing the position to 42,672 shares worth $6.69M. The position accounts for 0.05% of the portfolio, ranked #311.

Vident Advisory first reported a position in NVS in Q3 2023 and has held it in 12 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

• Vident Advisory held 42,672 shares of Novartis worth $6.69M as of Q2 2026.
• Vident Advisory bought 856 Novartis shares in Q2 2026, an estimated $128K.
• Novartis made up 0.05% of Vident Advisory's portfolio in Q2 2026, its #311 holding.
• Vident Advisory first reported a position in Novartis in Q3 2023 and has held it in 12 quarters since.
• 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.